This week's View explores the effectiveness of combination diuretic regimens to overcome loop diuretic resistance in acute heart failure; the association among race and disease expression, care provision, and clinical outcomes among patients with hypertrophic cardiomyopathy; and the optimal strategy for antiplatelet therapy in patients with lower extremity peripheral artery disease after endovascular revascularization.

Subscribe on iTunes | Subscribe on Google Play

Keywords: EaglesEyeView, African Americans, Arrhythmias, Cardiac, Atrial Fibrillation, Cardiomyopathies, Cardiomyopathy, Hypertrophic, Familial, Defibrillators, Implantable, Endovascular Procedures, Genetic Testing, Health Status Disparities, Heart Arrest, Heart Failure, Heart Transplantation, Heart-Assist Devices, Hemorrhage, Lower Extremity, Mutation, Myocardial Revascularization, Outcome Assessment, Health Care, Peripheral Arterial Disease, Platelet Aggregation Inhibitors, Sarcomeres, Secondary Prevention, Stroke, Vascular Diseases, Cardiac Surgical Procedures, Coronary Angiography, Chlorothiazide, Diuretics, Furosemide, Heart Failure, Metolazone, Sodium, Sodium Potassium Chloride Symporter Inhibitors, Weight Loss

< Back to Listings